腹腔镜与机器人手术治疗炎症性肠病的系统评价与荟萃分析
机器人组手术时间更长,但中转率降低,总体并发症、外科并发症和内科并发症相当,住院时间略短。机器人手术是可行选择,但证据有限,需成本分析支持。
要点
- 机器人组手术时间显著长于腹腔镜组,各术式差异有统计学意义。
- 机器人组中转率在回盲部切除中显著降低,在IPAA中差异无统计学意义。
- 两组总体并发症、外科并发症和内科并发症相当,住院时间机器人组略短。
核心结论
- 机器人手术在炎症性肠病患者中较腹腔镜手术略有优势,但证据有限,需成本分析论证其较高费用。
主要发现
- 机器人组手术时间更长:回盲部切除增加67.3(p<0.01),结肠次全切除增加63.5(p<0.001),IPAA增加39.7(p<0.001)。
- 中转率:回盲部切除降低0.73(p=0.02),IPAA降低0.4(p=0.5)。
- 总体并发症:回盲部切除0.1(p=0.64),结肠次全切除-0.09(p=0.4),IPAA 0.01(p=0.96)。
- 外科并发症:回盲部切除-0.58(p=0.01),结肠次全切除-0.2(p=0.09),IPAA-0.3(p=0.2)。
- 内科并发症:回盲部切除-0.18(p=0.7),结肠次全切除-0.2(p=0.2),IPAA 0.56(p=0.48)。
临床怎么用
- 机器人手术可作为炎症性肠病患者的微创选择之一,尤其适用于需降低中转率的回盲部切除。
- 选择机器人手术时应权衡其较长手术时间与较高费用,并结合中心经验个体化决策。
局限性
- 未进行成本分析,无法论证机器人手术较高费用的合理性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Refractory inflammatory bowel disease (IBD) often requires surgery. Ulcerative colitis (UC) usually needs proctocolectomy, while Crohn's disease (CD often involves multiple surgeries, with ileocecal resection (ICR) being the most common. Minimally invasive approaches offer faster recovery and fewer complications. Laparoscopy is established for IBD. Robotic surgery has shown its potential. This review updates evidence on robotic versus laparoscopic techniques in IBD surgery. METHODS: PubMed, Scopus, CINAHL, and Cochrane databases were searched for papers comparing laparoscopic versus robotic surgery in IBD patients. Odds-ratio and weighted mean differences were calculated using models with random-effects. Risk of bias was evaluated with the Newcastle-Ottawa scale. RESULTS: Fifteen papers reporting the outcomes of 13.225 patients were included. Papers were stratified into three categories: ICR for CD, Subtotal colectomy (SC) for UC, and proctectomy and ileal pouch-anal anastomosis (IPAA) for UC. Higher operative time was reported in the robotic cohorts (ICR 67.3 p < 0.01, SC 63.5 p < 0.001, and IPAA 39.7 p < 0.001), with a reduced conversion rate (ICR - 0.73 p = 0.02, IPAA - 0.4 p = 0.5). Outcomes were comparable for overall complications (ICR 0.1 p = 0.64, SC - 0.09 p = 0.4, and IPAA 0.01 p = 0.96) surgical (ICR - 0.58 p = 0.01, SC - 0.2 p = 0.09, IPAA - 0.3 p = 0.2) and medical complications (ICR - 0.18 p = 0.7, SC - 0.2 p = 0.2, and IPAA 0.56 p = 0.48). A slight advantage in hospital stay has been documented (ICR - 0.66 p = 0.03, SC - 0.7 p = 0.28, and IPAA - 0.29 p = 0.5). CONCLUSIONS: This meta-analysis demonstrates a slight advantage of robotic surgery over laparoscopy in IBD patients. While robotic surgery is a valid option, evidence is limited, and a cost analysis is required to justify its higher expense.
引用
- Lucarini A, Belloni E, Litchinko A, et al. Comparison of laparoscopic and robotic surgery for inflammatory bowel disease: a systematic review and meta-analysis. Surg Endosc. 2026. PMID: 41840085. doi:10.1007/s00464-026-12740-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。